IDO1 and metastatic neoplasm: To explore the reasons for HMP1G NPs‐mediated unique ability to remodel the tumor immunosuppressive microenvironment thereby inhibiting the growth of primary and distant metastatic tumors in the BRCA mouse model, we first analyzed the effects of IDO1 and its metabolites on the mammary microenvironment in both normal and tumor tissues of the mice.